Studies of hospitalized COVID-19 patients suggest an increased risk of arterial thromboembolism (ATE) and venous thromboembolism (VTE). The incidence and determinants of these events after COVID-19 diagnosis in the ambulatory setting are less clear.
This presentation estimates the risk of ATE and VTE among patients with ambulatory-diagnosed COVID-19 before and during COVID-19 vaccine availability compared to patients with ambulatory-diagnosed influenza. It was presented at the 39th International Conference on Pharmacoepidemiology and Therapeutic Risk Management.
Noelle M. Cocoros, Sarah Dutcher, John G. Connolly, Silvia Perez-Vilar, Dena M. Carbonari, Terese DeFor, Djeneba Audrey Djibo, Laura Harrington, Laura Hou, Sean Hennessy, Rebecca Hubbard, Maria Kempner, Jennifer Kuntz, Cheryl McMahill-Walraven, Jolene Mosley, Pamala A. Pawloski, Andrew Petrone, Allyson Pishko, Meighan Rogers Driscoll, Claudia Steiner, Yunping Zhou, Vincent Lo Re III